352 related articles for article (PubMed ID: 29945565)
1. MicroRNAs as markers of progression in cervical cancer: a systematic review.
Pardini B; De Maria D; Francavilla A; Di Gaetano C; Ronco G; Naccarati A
BMC Cancer; 2018 Jun; 18(1):696. PubMed ID: 29945565
[TBL] [Abstract][Full Text] [Related]
2. microRNAs are biomarkers of oncogenic human papillomavirus infections.
Wang X; Wang HK; Li Y; Hafner M; Banerjee NS; Tang S; Briskin D; Meyers C; Chow LT; Xie X; Tuschl T; Zheng ZM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4262-7. PubMed ID: 24591631
[TBL] [Abstract][Full Text] [Related]
3. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
4. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
5. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
Gao D; Zhang Y; Zhu M; Liu S; Wang X
PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection.
Zamani S; Sohrabi A; Hosseini SM; Rahnamaye-Farzami M; Akbari A
Microrna; 2019; 8(2):110-115. PubMed ID: 30332981
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated microRNAs involved in the progression of cervical neoplasm.
Zeng K; Zheng W; Mo X; Liu F; Li M; Liu Z; Zhang W; Hu X
Arch Gynecol Obstet; 2015 Oct; 292(4):905-13. PubMed ID: 25851497
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of microRNA expression profiling studies in human cervical cancer.
Li MY; Hu XX
Med Oncol; 2015 Jun; 32(6):510. PubMed ID: 25920605
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.
Cheung TH; Man KN; Yu MY; Yim SF; Siu NS; Lo KW; Doran G; Wong RR; Wang VW; Smith DI; Worley MJ; Berkowitz RS; Chung TK; Wong YF
Cell Cycle; 2012 Aug; 11(15):2876-84. PubMed ID: 22801550
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
Nascimento NPG; Gally TB; Borges GF; Campos LCG; Kaneto CM
BMC Cancer; 2022 Aug; 22(1):862. PubMed ID: 35933332
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation regulated microRNAs in human cervical cancer.
Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
[TBL] [Abstract][Full Text] [Related]
12. miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development.
Ribeiro J; Marinho-Dias J; Monteiro P; Loureiro J; Baldaque I; Medeiros R; Sousa H
Biomed Res Int; 2015; 2015():304584. PubMed ID: 26180794
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
14. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.
Li Y; Wang F; Xu J; Ye F; Shen Y; Zhou J; Lu W; Wan X; Ma D; Xie X
J Pathol; 2011 Aug; 224(4):484-95. PubMed ID: 21503900
[TBL] [Abstract][Full Text] [Related]
15. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia.
Kawai S; Fujii T; Kukimoto I; Yamada H; Yamamoto N; Kuroda M; Otani S; Ichikawa R; Nishio E; Torii Y; Iwata A
Sci Rep; 2018 May; 8(1):7070. PubMed ID: 29728572
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression associated with low-grade cervical intraepithelial neoplasia outcomes.
Winters AN; Berry AK; Dewenter TA; Chowdhury NU; Wright KL; Cameron JE
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11969-11978. PubMed ID: 37421453
[TBL] [Abstract][Full Text] [Related]
17. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
18. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNAs as biomarkers of cervical carcinogenesis: a systematic review.
Nagandla K; Lin KH; Chitra E; Jamli MFBM
Obstet Gynecol Sci; 2021 Sep; 64(5):419-436. PubMed ID: 34384196
[TBL] [Abstract][Full Text] [Related]
20. miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200.
Fang W; Shu S; Yongmei L; Endong Z; Lirong Y; Bei S
Sci Rep; 2016 Sep; 6():33229. PubMed ID: 27615604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
